Developing imaging agents to detect and treat atherosclerosis
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11019782
This study is testing new tools that can help find weak spots in blood vessels caused by atherosclerosis, which can lead to heart attacks and strokes, so that patients can get better care and treatment sooner.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11019782 on ClinicalTrials.gov |
What this research studies
This research focuses on creating targeted molecular probes that can identify vulnerable plaques in blood vessels associated with atherosclerosis, a condition that can lead to serious cardiovascular events like heart attacks and strokes. By utilizing advanced imaging techniques, specifically positron emission tomography (PET), the study aims to track the progression of these plaques and monitor treatment responses. Patients may benefit from improved detection methods that could lead to earlier interventions and better management of their cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for cardiovascular diseases, particularly those with known atherosclerosis or related conditions.
Not a fit: Patients without atherosclerosis or those who do not have risk factors for cardiovascular diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective detection and treatment of atherosclerosis, potentially reducing the risk of heart attacks and strokes for patients.
How similar studies have performed: Previous research has shown promise in using targeted imaging agents for cardiovascular diseases, suggesting that this approach could be effective.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIU, YONGJIAN — WASHINGTON UNIVERSITY
- Study coordinator: LIU, YONGJIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Atherosclerotic Cardiovascular Disease, atherosclerotic disease, atherosclerotic vascular disease